# DANONE

> DANONE is a VC fund in Paris backing Biotechnology and Chemical. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Paris, France
- Total investments: 4
- Last investment: Mar 2026
- Lead investor: 25%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/danone
- X (Twitter): http://twitter.com/DanoneGroup
- Website: http://www.danone.com/en/#
- Facebook: http://www.facebook.com/groupe.danone

Danone is a France-based food company that provides dairy products, early life nutrition, waters, and medications.

## Contacts

5 contacts available for DANONE. Shizune tracks 9 team members at DANONE. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/danone?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 75% |
| Chemical | 2 | 50% |
| Dairy | 1 | 25% |
| Farming | 1 | 25% |
| Agriculture | 1 | 25% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Post-IPO Equity | 2 | 50% |
| Series B | 1 | 25% |
| Series G | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 1 | 25% |
| Israel | 1 | 25% |
| United States | 1 | 25% |
| The Netherlands | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Antoine de Saint-Affrique | CEO | 1 | — |
| Andy Prabowo | Digital Business Solution Manager | 0 | — |
| Antoine Borde | Global eCommerce Director | 0 | https://shizune.co/investors/profile/antoine-borde |
| Flemming Morgan | Executive Vice-President, Medical Nutrition | 0 | — |
| Francisco Camacho | Executive Vice-President., Waters | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Standing Ovation | Standing Ovation develops food technology solutions using precision fermentation to produce animal-free dairy proteins for food manufacturing. The company creates casein proteins through engineered microorganisms, enabling the production of cheese and other dairy products without relying on traditional animal farming.Its core product, AdvancedCasein, is designed to replicate the functional, nutritional, and taste properties of conventional milk proteins while reducing dependence on livestock-based supply chains. The production process involves cultivating microorganisms, feeding them plant-based inputs, and extracting proteins that can be incorporated into standard dairy processing methods. Standing Ovation applies these proteins in the development of cheese alternatives that follow traditional cheesemaking techniques, allowing compatibility with existing manufacturing systems. The resulting products are lactose-free and aim to maintain similar texture and performance characteristics as conventional dairy ingredients in food applications. | $28.6M | Series B | Mar 31, 2026 |  |
| Wilk | Wilk develops lab-cultured cow milk from mammary cells. Wilk aims to produce milk that approximates the composition of commercial cow milk, free of synthetic or plant additives, and with a lower hormones and antibiotics content than that of the traditional product. | $450K | Post-IPO Equity | Apr 03, 2023 |  |
| Origin Materials | Origin is the carbon negative materials company. The Origin platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Origin has developed a platform for turning the carbon found in inexpensive, plentiful, non-food biomass such as sustainable wood residuesinto useful materials while capturing carbon in the process. Origin’s patented technology platform can help revolutionize the production of a wide range of end products, including clothing, textiles, plastics, packaging, car parts, tires, carpeting, toys, and more with a ~$1 trillion addressable market. | $200M | Post-IPO Equity | Jun 25, 2021 |  |
| Avantium | Avantium is a leading technology company specialized in advanced high-throughput R&D for applications in the energy, chemicals and pharmaceutical industries. The company's headquarters and laboratories are located in Amsterdam, in the Netherlands.Avantium's proprietary high-throughput technology enables a faster and morecost-effective development of new and improved products and production processes. Using its unique rational approach towards the design of experiments and data analysis, Avantium is capable of accomplishing innovations with superior success rate. Avantium has demonstrated the validity and commercial viability of its technology by successfully providing research services and tools to more than 70 companies worldwide, including many industry leaders. The company's mission is to increase the success rate and economics of product and process development.Building on its expertise and track record in the energy, chemicals and pharmaceutical industries, Avantium focuses on developing products in two fields:new biofuels and bio-based chemicals, and new crystal forms of marketed drugs under patent.Avantium's strategy is to progress its development programs and exploit the commercial value of its expanding patent portfolio by securing value-adding partnerships during the coming years. Avantium seeks continuous expansion of its profitable services and tools business.Avantium has assembled a team of highly educated professionals who are experts in catalysis, crystallography, organic chemistry, engineering of robotic systems, process engineering, statistics, cheminformatics and software development. Its teams collaborate closely with partner R&D organizations. | $42.1M | Series G | May 22, 2014 |  |

4 of 4 investments shown.

## Co-investors
- [AECI](https://shizune.co/investors/profile/aeci) — VC Fund, 1 deal together
- [Aescap Venture](https://shizune.co/investors/profile/aescap-venture) — VC Fund, 1 deal together
- ALPLA — VC Fund, 1 deal together
- [Apollo](https://shizune.co/investors/profile/apollo-global-management-llc) — VC Fund, 1 deal together
- [Astanor Ventures](https://shizune.co/investors/profile/astanor-ventures) — VC Fund, 1 deal together
- [Aster](https://shizune.co/investors/profile/aster-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund
- [KB Securities](https://shizune.co/investors/profile/kb-securities) — VC Fund
- [Frazier Healthcare Partners](https://shizune.co/investors/profile/frazier-healthcare-ventures) — VC Fund

## FAQ

### What does DANONE invest in?

DANONE invests primarily in Biotechnology, Chemical and Dairy startups, most often at Post-IPO Equity and Series B stage. Most of the 4 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact DANONE?

Public channels for DANONE include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at DANONE?

The team at DANONE includes Antoine de Saint-Affrique (CEO), Andy Prabowo (Digital Business Solution Manager) and Antoine Borde (Global eCommerce Director), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co